See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Sam Schulman

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	36907381	0	Candeloro M, Valeriani E, Monreal M, et al. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis. J Thromb Haemost. 2023 Mar 10:S1538-7836(23)00176-9. doi: 10.1016/j.jtha.2023.03.002.
	36710196	0	Caiano L, Kovacs MJ, Lazo-Langner A, et al. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. J Thromb Haemost. 2022 Dec 30:S1538-7836(22)19071-9. doi: 10.1016/j.jtha.2022.12.021.
	36434811	0	Hansen-Barkun C, Martel M, Douketis J, et al. Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy. Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002076.
	36294316	0	Kyriakoulis KG, Dimakakos E, Kyriakoulis IG, et al. Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials. J Clin Med. 2022 Oct 11;11(20). pii: jcm11205997. doi: 10.3390/jcm11205997.
	36206783	0	Aibar J, Schulman S. Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost. 2021 Sep;47(6):e1-e2. doi: 10.1055/s-0042-1757330. Epub 2022 Oct 7.
	36200348	0	Shaw JR, Li N, Nixon J, et al. Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. J Thromb Haemost. 2022 Dec;20(12):2953-2963. doi: 10.1111/jth.15901. Epub 2022 Oct 18.
	35974661	0	Candeloro M, Di Nisio M, Potere N, et al. Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants. J Am Geriatr Soc. 2022 Aug 16. doi: 10.1111/jgs.18001.
	35918731	0	Holbrook AM, Vidug K, Yoo L, et al. Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial. Pilot Feasibility Stud. 2022 Aug 2;8(1):166. doi: 10.1186/s40814-022-01130-z.
	35906715	0	Spyropoulos AC, Connors JM, Douketis JD, et al. Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Jul 7. doi: 10.1111/jth.15809.
	35877546	0	Abdulrehman J, Elbaz C, Aziz D, et al. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis. Br J Haematol. 2022 Jul 25. doi: 10.1111/bjh.18331.
	35793687	0	Candeloro M, Schulman S. Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis. Semin Thromb Hemost. 2022 Jul 6. doi: 10.1055/s-0042-1749661.
	35790272	0	Dimakakos E, Gomatou G, Catalano M, et al. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art. Anticancer Res. 2022 Jul;42(7):3261-3274. doi: 10.21873/anticanres.15815.
	35772400	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part VIII. Semin Thromb Hemost. 2022 Jun;48(4):405-406. doi: 10.1055/s-0042-1748886. Epub 2022 Jun 30.
	35707621	0	Eagle GE, Schulman S. High Factor VIII Levels and Recurrent Thromboembolism in Patients with and without Inflammatory Bowel Disease: A Retrospective Comparative Study. TH Open. 2022 Jun 13;6(2):e147-e153. doi: 10.1055/a-1827-7464. eCollection 2022 Apr.
	35679460	0	Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027.
	35613465	0	Candeloro M, Valeriani E, Monreal M, et al. Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis. Blood Adv. 2022 May 25. pii: 485361. doi: 10.1182/bloodadvances.2022007961.
	35362102	0	Schulman S, Carlson V, Serrano PE, et al. Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study. J Surg Oncol. 2022 Apr 1. doi: 10.1002/jso.26876.
	35224414	0	Candeloro M, Eikelboom JW, Chan N, et al. Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohort. Res Pract Thromb Haemost. 2022 Feb 17;6(2):e12650. doi: 10.1002/rth2.12650. eCollection 2022 Feb.
	35015038	0	Goldenberg NA, Kittelson JM, Abshire TC, et al. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
	34852380	0	Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263.
	34807722	0	Le Gal G, Kovacs MJ, Bertoletti L, et al. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981.
	34753191	0	Khan F, Rahman A, Tritschler T, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
	34518263	0	Galanaud JP, Abdulrehman J, Lazo-Langner A, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e049557. doi: 10.1136/bmjopen-2021-049557.
	34470058	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part VII. Semin Thromb Hemost. 2021 Sep;47(6):621-622. doi: 10.1055/s-0041-1725945. Epub 2021 Sep 1.
	34453675	0	Goldhaber SZ, Ageno W, Casella IB, et al. Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Aug 28. pii: 10.1007/s11239-021-02463-x. doi: 10.1007/s11239-021-02463-x.
	34345092	0	Gabara C, Solarat B, Castro P, et al. Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients. Med Intensiva (Engl Ed). 2021 Jul 30. pii: S0210-5691(21)00178-9. doi: 10.1016/j.medin.2021.07.004.
	34318606	0	Candeloro M, van Es N, Cantor N, et al. Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost. 2021 Oct;19(10):2618-2628. doi: 10.1111/jth.15476. Epub 2021 Aug 8.
	34255420	0	Wik HS, Kahn SR, Eriksson H, et al. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost. 2021 Oct;19(10):2495-2503. doi: 10.1111/jth.15449. Epub 2021 Jul 28.
	34108229	0	Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205.
	33971682	0	Schellong S, Ageno W, Casella IB, et al. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Semin Thromb Hemost. 2021 May 10. doi: 10.1055/s-0041-1729169.
	33971678	0	Aibar J, Schulman S. Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost. 2021 Sep;47(6):709-723. doi: 10.1055/s-0041-1725057. Epub 2021 May 10.
	33792175	0	Khorsand N, Beyer-Westendorf J, Sarode R, et al. Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost. 2021 Apr;19(4):1112-1115. doi: 10.1111/jth.15222.
	33537540	0	Douketis JD, Syed S, Li N, et al. A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Res Pract Thromb Haemost. 2020 Dec 16;5(1):159-167. doi: 10.1002/rth2.12430. eCollection 2021 Jan.
	33368114	0	Kearon C, Carrier M, Gu CS, et al. Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial. Semin Thromb Hemost. 2020 Nov;46(8):977-985. doi: 10.1055/s-0040-1718891. Epub 2020 Dec 23.
	33368109	0	Schulman S. Recent Advances in Thrombosis and Hemostasis: Part VI. Semin Thromb Hemost. 2020 Nov;46(8):863-864. doi: 10.1055/s-0040-1715794. Epub 2020 Dec 23.
	33306241	0	Valeriani E, Di Nisio M, Riva N, et al. Clinical history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost. 2021 Apr;19(4):983-991. doi: 10.1111/jth.15214. Epub 2021 Feb 24.
	33099284	0	Schulman S, Hu Y, Konstantinides S. Venous Thromboembolism in COVID-19. Thromb Haemost. 2020 Dec;120(12):1642-1653. doi: 10.1055/s-0040-1718532. Epub 2020 Oct 24.
	33007077	0	Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
	32969288	0	Tafur AJ, Clark NP, Spyropoulos AC, et al. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. J Am Heart Assoc. 2020 Oct 20;9(19):e017316. doi: 10.1161/JAHA.120.017316. Epub 2020 Sep 24.
	32968991	0	Aibar J, Schulman S. New-Onset Atrial Fibrillation in Sepsis: A Narrative Review. Semin Thromb Hemost. 2021 Feb;47(1):18-25. doi: 10.1055/s-0040-1714400. Epub 2020 Sep 23.
	32851572	0	Ageno W, Casella IB, Chee KH, et al. Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Apr;51(3):561-570. doi: 10.1007/s11239-020-02239-9.
	32756938	0	Shaw JR, Li N, Vanassche T, et al. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Adv. 2020 Aug 11;4(15):3520-3527. doi: 10.1182/bloodadvances.2020002335.
	32735828	0	Schulman S. Is venous thromboembolism a preventable cause of death? Lancet Haematol. 2020 Aug;7(8):e555-e556. doi: 10.1016/S2352-3026(20)30219-2.
	32619346	0	Di Nisio M, Valeriani E, Riva N, et al. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost. 2020 Jul;18(7):1562-1568. doi: 10.1111/jth.14836.
	32578414	0	Hwang HG, Kim YK, Kim MS, et al. Prophylaxis of Venous Thromboembolism in Patients with Infectious Disease. Tuberc Respir Dis (Seoul). 2020 Jul;83(3):255-256. doi: 10.4046/trd.2020.0029. Epub 2020 Apr 29.
	32526791	0	Schulman S, Konstantinides S, Hu Y, et al. Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158]. Thromb Haemost. 2020 Aug;120(8):1143-1146. doi: 10.1055/s-0040-1712913. Epub 2020 Jun 11.
	32496023	0	Tritschler T, Kraaijpoel N, Girard P, et al. Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Jun;18(6):1495-1500. doi: 10.1111/jth.14769.
	32473596	0	Bikdeli B, Madhavan MV, Gupta A, et al. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul;120(7):1004-1024. doi: 10.1055/s-0040-1713152. Epub 2020 May 30.
	32392613	0	Schulman S. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism. Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
	32346486	0	Legault K, Blostein M, Carrier M, et al. A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot Feasibility Stud. 2020 Apr 25;6:52. doi: 10.1186/s40814-020-00594-1. eCollection 2020.
	32325043	0	Goldhaber SZ, Ageno W, Casella IB, et al. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE Study. Am J Med. 2020 Aug;133(8):936-945. doi: 10.1016/j.amjmed.2020.03.036. Epub 2020 Apr 20.
	32311448	0	Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
	32289164	0	Izcovich A, Criniti JM, Popoff F, et al. Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis. Blood Adv. 2020 Apr 14;4(7):1539-1553. doi: 10.1182/bloodadvances.2020001513.
	32202042	0	Valeriani E, Porreca E, Weitz JI, et al. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis. J Thromb Haemost. 2020 Jul;18(7):1661-1671. doi: 10.1111/jth.14807. Epub 2020 Apr 16.
	32073218	0	Tritschler T, Kraaijpoel N, Langlois N, et al. Development of a standardized definition of pulmonary embolism-related death: A cross-sectional survey of international thrombosis experts. J Thromb Haemost. 2020 Jun;18(6):1415-1420. doi: 10.1111/jth.14775. Epub 2020 Mar 30.
	32040553	0	Khatib R, Ross S, Kennedy SA, et al. Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis. Blood Adv. 2020 Feb 11;4(3):500-513. doi: 10.1182/bloodadvances.2019001223.
	32011635	0	Spyropoulos AC, Schulman S, Douketis JD. Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant-Reply. JAMA Intern Med. 2020 Feb 1;180(2):333-334. doi: 10.1001/jamainternmed.2019.5851.
	31774957	0	Kearon C, de Wit K, Parpia S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. N Engl J Med. 2019 Nov 28;381(22):2125-2134. doi: 10.1056/NEJMoa1909159.
	31675758	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part V. Semin Thromb Hemost. 2019 Nov;45(8):757-759. doi: 10.1055/s-0039-1700490. Epub 2019 Nov 1.
	31624782	0	Murray S, McLintock C, Lazure P, et al. Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international study. Res Pract Thromb Haemost. 2019 Jun 28;3(4):626-638. doi: 10.1002/rth2.12237. eCollection 2019 Oct.
	31434018	0	Xu Y, Schulman S, Dowlatshahi D, et al. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding. Thromb Res. 2019 Oct;182:12-19. doi: 10.1016/j.thromres.2019.07.026. Epub 2019 Aug 2.
	31415251	0	Grottke O, Schulman S. Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors. Anesthesiology. 2019 Nov;131(5):1153-1165. doi: 10.1097/ALN.0000000000002910.
	31380891	0	Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431.
	31340984	0	Khan F, Rahman A, Carrier M, et al. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.
	31033194	0	Kearon C, Parpia S, Spencer FA, et al. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study. J Thromb Haemost. 2019 Jul;17(7):1144-1152. doi: 10.1111/jth.14458. Epub 2019 May 20.
	30822795	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part IV. Semin Thromb Hemost. 2019 Mar;45(2):130-131. doi: 10.1055/s-0039-1678721. Epub 2019 Mar 1.
	30743281	0	Piran S, Schulman S. Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Narrative Review. Semin Thromb Hemost. 2019 Mar;45(2):150-156. doi: 10.1055/s-0039-1678720. Epub 2019 Feb 11.
	30658963	0	Piran S, Khatib R, Schulman S, et al. Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Adv. 2019 Jan 22;3(2):158-167. doi: 10.1182/bloodadvances.2018024133.
	30657628	0	Abdoellakhan RA, Beyer-Westendorf J, Schulman S, et al. Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding. J Thromb Haemost. 2019 Mar;17(3):499-506. doi: 10.1111/jth.14388. Epub 2019 Feb 13.
	30559261	0	Piran S, Schulman S. Treatment of bleeding complications in patients on anticoagulant therapy. Blood. 2019 Jan 31;133(5):425-435. doi: 10.1182/blood-2018-06-820746. Epub 2018 Dec 17.
	30487292	0	van der Wall SJ, van der Pol LM, Ende-Verhaar YM, et al. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review. Eur Respir Rev. 2018 Nov 28;27(150). pii: 27/150/180094. doi: 10.1183/16000617.0094-2018. Print 2018 Dec 31.
	30349887	0	Piran S, Traquair H, Chan N, et al. Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study. Res Pract Thromb Haemost. 2018 Aug 29;2(4):684-688. doi: 10.1002/rth2.12146. eCollection 2018 Oct.
	30261356	0	Dube C, Douketis JD, Moffat KA, et al. Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time. Thromb Res. 2018 Nov;171:62-67. doi: 10.1016/j.thromres.2018.09.051. Epub 2018 Sep 19.
	30201588	0	Schulman S. Splanchnic vein thrombosis: what are the long-term risks? Lancet Haematol. 2018 Oct;5(10):e431-e432. doi: 10.1016/S2352-3026(18)30137-6. Epub 2018 Sep 7.
	30108204	0	Senzolo M, Riva N, Dentali F, et al. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis. Clin Transl Gastroenterol. 2018 Aug 15;9(8):176. doi: 10.1038/s41424-018-0043-2.
	30046730	0	Shaw JR, Woodfine JD, Douketis J, et al. Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2018 Feb 16;2(2):282-290. doi: 10.1002/rth2.12076. eCollection 2018 Apr.
	30012319	0	Schulman S, Aisenberg J. Are NSAIDs Double Trouble? J Am Coll Cardiol. 2018 Jul 17;72(3):268-270. doi: 10.1016/j.jacc.2018.04.062. Epub 2018 Jul 9.
	29857347	0	Schulman S. Recent Advances in Thrombosis and Hemostasis - Part III. Semin Thromb Hemost. 2018 Jun;44(4):312-314. doi: 10.1055/s-0038-1654717. Epub 2018 Jun 1.
	29795666	0	Xu Y, Shoamanesh A, Schulman S, et al. Correction: Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts. PLoS One. 2018 May 24;13(5):e0198031. doi: 10.1371/journal.pone.0198031. eCollection 2018.
	29703478	0	Piran S, Schulman S. Management of recurrent venous thromboembolism in patients with cancer: A review. Thromb Res. 2018 Apr;164 Suppl 1:S172-S177. doi: 10.1016/j.thromres.2017.12.019.
	29564837	0	Schulman S, Gross PL, Ritchie B, et al. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thromb Haemost. 2018 May;118(5):842-851. doi: 10.1055/s-0038-1636541. Epub 2018 Mar 21.
	29564687	0	Piran S, Gabriel C, Schulman S. Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study. J Thromb Thrombolysis. 2018 May;45(4):486-495. doi: 10.1007/s11239-018-1645-y.
	29490924	0	Kearon C, Parpia S, Spencer FA, et al. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018 May 10;131(19):2151-2160. doi: 10.1182/blood-2017-09-805689. Epub 2018 Feb 28.
	29397541	0	Piran S, Traquair H, Chan N, et al. Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study. J Thromb Thrombolysis. 2018 May;45(4):557-561. doi: 10.1007/s11239-018-1626-1.
	29370183	0	Xu Y, Shoamanesh A, Schulman S, et al. Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts. PLoS One. 2018 Jan 25;13(1):e0191137. doi: 10.1371/journal.pone.0191137. eCollection 2018.
	29224638	0	Clark NP, Douketis JD, Hasselblad V, et al. Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial. Am Heart J. 2018 Jan;195:108-114. doi: 10.1016/j.ahj.2017.09.015. Epub 2017 Sep 21.
	29212129	0	Douketis JD, Spyropoulos AC, Anderson JM, et al. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6.
	29202209	0	Goldhaber SZ, Schulman S, Eriksson H, et al. Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Thromb Haemost. 2017 Nov;117(11):2045-2052. doi: 10.1160/TH17-03-0176. Epub 2017 Oct 4.
	29183221	0	Tarango C, Schulman S, Betensky M, et al. Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials. Expert Rev Hematol. 2018 Jan;11(1):37-44. doi: 10.1080/17474086.2018.1407241. Epub 2017 Dec 17.
	29170877	0	Piran S, Schulman S, Panju M, et al. Oral anticoagulant dosing, administration, and storage: a cross-sectional survey of Canadian health care providers. J Thromb Thrombolysis. 2018 Jan;45(1):180-185. doi: 10.1007/s11239-017-1585-y.
	29136562	0	Chai-Adisaksopha C, Iorio A, Hillis C, et al. Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis. Thromb Res. 2017 Dec;160:97-104. doi: 10.1016/j.thromres.2017.11.001. Epub 2017 Nov 11.
	29092088	0	Schulman S, Islam MS. Recent Advances in Thrombosis and Hemostasis-Part II. Semin Thromb Hemost. 2017 Nov;43(8):809-810. doi: 10.1055/s-0037-1605566. Epub 2017 Nov 1.
	29091811	0	Piran S, Bednar D, Drew B, et al. Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons. Thromb Res. 2017 Dec;160:38-40. doi: 10.1016/j.thromres.2017.10.016. Epub 2017 Oct 26.
	28939565	0	Khan F, Rahman A, Carrier M, et al. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis. BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950.
	28902373	0	Islam MS, Schulman S. Berzelius Symposium 93: International Conference on Thrombosis and Embolism. Semin Thromb Hemost. 2017 Nov;43(8):811-813. doi: 10.1055/s-0037-1605565. Epub 2017 Sep 8.
	28862285	0	Schulman S. Accumulating data on rivaroxaban for venous thromboembolism in clinical practice. Thromb Haemost. 2017 Oct 5;117(10):1840. doi: 10.1160/TH17-08-0573. Epub 2017 Sep 1.
	28835439	0	Majeed A, Agren A, Holmstrom M, et al. Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study. Blood. 2017 Oct 12;130(15):1706-1712. doi: 10.1182/blood-2017-05-782060. Epub 2017 Aug 23.
	28724590	0	Korompoki E, Filippidis FT, Nielsen PB, et al. Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. Neurology. 2017 Aug 15;89(7):687-696. doi: 10.1212/WNL.0000000000004235. Epub 2017 Jul 19.
	28594049	0	Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: Past, present and future. Thromb Haemost. 2017 Jun 28;117(7):1219-1229. doi: 10.1160/TH16-10-0823. Epub 2017 Jun 8.
	28483766	0	Schulman S. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy. Blood. 2017 Jun 22;129(25):3285-3293. doi: 10.1182/blood-2017-03-742304. Epub 2017 May 8.
	28424821	0	Schulman S, Singer D, Ageno W, et al. NOACs for treatment of venous thromboembolism in clinical practice. Thromb Haemost. 2017 Jun 28;117(7):1317-1325. doi: 10.1160/TH17-01-0065. Epub 2017 Apr 20.
	28364736	0	Schulman S. Bleeding Complications and Management on anticoagulant therapy. Semin Thromb Hemost. 2017 Nov;43(8):886-892. doi: 10.1055/s-0037-1602377. Epub 2017 Apr 1.
	28222322	0	Schulman S, Ritchie B, Nahirniak S, et al. Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study. Thromb Res. 2017 Apr;152:44-48. doi: 10.1016/j.thromres.2017.02.010. Epub 2017 Feb 16.
	28219635	0	Xu Y, Schulman S, Dowlatshahi D, et al. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study. Chest. 2017 Jul;152(1):81-91. doi: 10.1016/j.chest.2017.02.009. Epub 2017 Feb 17.
	28210989	0	Feuring M, Schulman S, Eriksson H, et al. Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER((R)), RE-COVER II, and RE-MEDY. J Thromb Thrombolysis. 2017 May;43(4):484-489. doi: 10.1007/s11239-017-1479-z.
	28123190	0	Carlin S, Pickering J, Schulman S. Appropriateness of Apixaban Dosing to Prevent Stroke in Patients with Atrial Fibrillation: A Pilot Study. Can J Hosp Pharm. 2016 Nov-Dec;69(6):449-453. doi: 10.4212/cjhp.v69i6.1607. Epub 2016 Dec 23.
	28004062	0	Majeed A, Wallvik N, Eriksson J, et al. Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis. Thromb Haemost. 2017 Feb 28;117(3):491-499. doi: 10.1160/TH16-07-0498. Epub 2016 Dec 22.
	27853808	0	Ageno W, Casella IB, Han CK, et al. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thromb Haemost. 2017 Jan 26;117(2):415-421. doi: 10.1160/TH16-07-0566. Epub 2016 Nov 17.
	27829265	0	Schulman S, Islam MS. Recent Advances in Thrombosis and Hemostasis - Part I. Semin Thromb Hemost. 2016 Nov;42(8):805-807. doi: 10.1055/s-0036-1593544. Epub 2016 Nov 9.
	27807306	0	Goldhaber SZ, Eriksson H, Kakkar A, et al. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER(R), RE-COVER II, and RE-MEDY. Vasc Med. 2016 Dec;21(6):506-514. doi: 10.1177/1358863X16668588. Epub 2016 Nov 1.
	27766049	0	Piran S, Schulman S. Management of venous thromboembolism: an update. Thromb J. 2016 Oct 4;14(Suppl 1):23. doi: 10.1186/s12959-016-0107-z. eCollection 2016.
	27764881	0	Schulman S. Update on the Treatment of Venous Thromboembolism. Semin Thromb Hemost. 2016 Nov;42(8):891-898. doi: 10.1055/s-0036-1592305. Epub 2016 Oct 20.
	27721141	0	Piran S, Schulman S. Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study. Thromb Res. 2016 Nov;147:97-101. doi: 10.1016/j.thromres.2016.09.030. Epub 2016 Oct 3.
	27471209	0	Klok FA, Hosel V, Clemens A, et al. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment. Eur Respir J. 2016 Nov;48(5):1369-1376. doi: 10.1183/13993003.00280-2016. Epub 2016 Jul 28.
	27411591	0	Goldhaber SZ, Schellong S, Kakkar A, et al. Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II. Thromb Haemost. 2016 Sep 27;116(4):714-21. doi: 10.1160/TH16-04-0271. Epub 2016 Jul 14.
	27388221	0	Fatima S, Holbrook A, Schulman S, et al. Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation. Thromb Res. 2016 Sep;145:143-8. doi: 10.1016/j.thromres.2016.06.015. Epub 2016 Jun 16.
	27346552	0	Boonyawat K, Wang L, Lazo-Langner A, et al. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial. Thromb Haemost. 2016 Aug 30;116(3):480-5. doi: 10.1160/TH16-04-0320. Epub 2016 Jun 23.
	27346176	0	Kittelson JM, Steg PG, Halperin JL, et al. Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation. Thromb Haemost. 2016 Aug 30;116(3):544-53. doi: 10.1160/TH15-12-1000. Epub 2016 Jun 23.
	27264036	0	Riva N, Ageno W, Schulman S, et al. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry. Lancet Haematol. 2016 Jun;3(6):e267-75. doi: 10.1016/S2352-3026(16)30020-5. Epub 2016 May 11.
	27067968	0	Schulman S, Shrum J, Majeed A. Management of bleeding complications in patients with cancer on DOACs. Thromb Res. 2016 Apr;140 Suppl 1:S142-7. doi: 10.1016/S0049-3848(16)30113-X.
	26989185	0	Schulman S. Less menorrhagia for women with VTE. Blood. 2016 Mar 17;127(11):1378-9. doi: 10.1182/blood-2016-01-692053.
	26908016	0	Majeed A, Hwang HG, Eikelboom JW, et al. Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events. Thromb Res. 2016 Apr;140:81-88. doi: 10.1016/j.thromres.2016.02.005. Epub 2016 Feb 22.
	26403199	0	Majeed A, Goldhaber SZ, Kakkar A, et al. Bleeding events with dabigatran or warfarin in patients with venous thromboembolism. Thromb Haemost. 2016 Jan;115(2):291-8. doi: 10.1160/TH15-04-0319. Epub 2015 Sep 24.
	26168152	0	Ageno W, Riva N, Schulman S, et al. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Intern Med. 2015 Sep;175(9):1474-80. doi: 10.1001/jamainternmed.2015.3184.
	26095867	0	Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015 Aug 27;373(9):823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22.
	25966905	0	Schulman S, Carrier M, Lee AY, et al. Perioperative Management of Dabigatran: A Prospective Cohort Study. Circulation. 2015 Jul 21;132(3):167-73. doi: 10.1161/CIRCULATIONAHA.115.015688. Epub 2015 May 12.
	25868460	0	Schulman JM, Majeed A, Mattsson E, et al. Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves. J Thromb Thrombolysis. 2015 Nov;40(4):430-6. doi: 10.1007/s11239-015-1216-4.
	25739680	0	Schulman S, Goldhaber SZ, Kearon C, et al. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer. Thromb Haemost. 2015 Jul;114(1):150-7. doi: 10.1160/TH14-11-0977. Epub 2015 Mar 5.
	25717178	0	Bacchus F, Schulman S. Clinical experience with the new oral anticoagulants for treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):513-9. doi: 10.1161/ATVBAHA.114.303396. Epub 2014 Aug 14.
	25682084	0	Schulman S. Treatment of venous thromboembolism with new oral anticoagulants according to patient risk. Semin Thromb Hemost. 2015 Mar;41(2):160-5. doi: 10.1055/s-0035-1544157. Epub 2015 Feb 15.
	25560712	0	Kearon C, Spencer FA, O'Keeffe D, et al. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med. 2015 Jan 6;162(1):27-34. doi: 10.7326/M14-1275.
	25541032	0	Magnusson M, Berndtsson M, Fischler B, et al. Thrombin generation test in children and adolescents with chronic liver disease. Thromb Res. 2015 Feb;135(2):382-7. doi: 10.1016/j.thromres.2014.11.040. Epub 2014 Dec 13.
	25048833	0	Masotti L, Lorenzini G, Seravalle C, et al. Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report. J Thromb Thrombolysis. 2015 May;39(4):427-33. doi: 10.1007/s11239-014-1112-3.